Charge-based supramolecular peptide nanocomplexes for oral delivery via transporter-driven endocytosis

Park, S. H.*, Ma, G.*, Park, S. J.*, Yang, S. B., Seo, M., Lee, J. H., … Park, J.

Biomaterials329IF 13.6상위 2.8%doi:10.1016/j.biomaterials.2025.123903

An in situ immunogenicity-amplifying payload delivery system for immunotherapy of KRAS-mutant cancer

Park, S. J., Cho, Y. S., Lee, J. H., Kim, S. Y., Byun, Y., Park, J., & Kim, H. R.

Journal of Controlled Release389IF 12.4상위 3.2%doi:10.1016/j.jconrel.2025.114380

Albumin uptake through FcRn promotes tumor-associated macrophage maturation and albumin-bound immunotherapy response

Hu, H., Jiang, F., Park, S. J., … Miller, M. A.

Cell Reports45(10), 118010IF 7.7상위 9%doi:10.1016/j.celrep.2026.118010

Doxorubicin-loaded multilayer nanoparticles with enhanced antitumor efficacy and reduced cardiotoxicity

Kil, Y. C., Kim, Y., Choi, A., Kim, J. Y., Park, S. J., Byun, Y., … Yuk, S. H.

Macromolecular ResearchIF 3.7상위 30%doi:10.1007/s13233-025-00468-6

Cell-penetrating peptide like anti-PD-L1 peptide conjugate-based self-assembled nanoparticles for immunogenic photodynamic therapy

Lee, J. H.*, Yang, S. B.*, Park, S. J.*, Kweon, S., Ma, G., Seo, M., … Park, J.

ACS Nano19(2), 2870–2889IF 17.3상위 6%doi:10.1021/acsnano.4c16128

Immune-chemo combination therapy using doxorubicin/viral epitope Pluronic nanoparticles

Kil, Y. C., Kim, Y., Choi, A., Kim, J. Y., Park, S. J., Byun, Y., … Yuk, S. H.

Journal of Pharmaceutical InvestigationIF 5.3상위 9.7%doi:10.1007/s40005-025-00781-3

Immune modulation of the liver metastatic colorectal cancer microenvironment via the oral CAPOX-mediated cGAS-STING pathway

Park, S. J., Kweon, S., Moyo, M. K., Kim, H., Choi, J. U., Lee, N. K., … Byun, Y.

Biomaterials310IF 14.0상위 2.8%doi:10.1016/j.biomaterials.2024.122625

Stimulating macropinocytosis of peptide-drug conjugates through DNA-dependent protein kinase inhibition for treating KRAS-mutant cancer

Kim, H.*, Park, S. J.*, Cho, Y. S., Moyo, M. K., Choi, J. U., Lee, N. K., … Byun, Y.

Journal of Controlled Release372, 176–193IF 12.4상위 3.2%doi:10.1016/j.jconrel.2024.06.028

Nano-anticoagulant based on carrier-free low molecular weight heparin and octadecylamine with an albumin shuttling effect

Lee, J. H.*, Lim, H.*, Ma, G., Kweon, S., Park, S. J., Seo, M., … Park, J.

Nature Communications15(1)IF 18.1상위 5.6%doi:10.1038/s41467-024-50819-7

Coordinated ASBT and EGFR mechanisms for optimized liraglutide nanoformulation absorption in the GI tract

Kweon, S., Park, S. J., Lee, H. K., Kang, S. H., Chang, K. Y., Choi, J. U., … Byun, Y.

International Journal of Nanomedicine19, 2973–2992IF 8.7상위 5.2%doi:10.2147/IJN.S442617

Synergistic anticancer immunity in metastatic triple-negative breast cancer through an in situ amplifying peptide-drug conjugate

Kim, H., Park, S. J., Cho, Y. S., Ko, Y. G., Kim, S. Y., & Byun, Y.

Journal of Controlled Release375, 681–697IF 12.4상위 3.2%doi:10.1016/j.jconrel.2024.07.074

Macropinocytosis-targeted peptide-docetaxel conjugate for bystander pancreatic cancer treatment

Cho, Y. S.*, Cho, H. H.*, Kim, H., Park, S. J., Yeo, J. H., Ko, Y. G., … Byun, Y.

Journal of Controlled Release376, 829–841IF 12.4상위 3.2%doi:10.1016/j.jconrel.2024.10.070

Design of chimeric GLP-1A using oligomeric bile acids to utilize transporter-mediated endocytosis for oral delivery

Kweon, S., Lee, J. H., Yang, S. B., Park, S. J., Subedi, L., Shim, J. H., … Park, J. W.

Biomaterials Research27(1)IF 15.9상위 2.55%doi:10.1186/s40824-023-00421-7

A novel oral metronomic chemotherapy provokes tumor specific immunity resulting in colon cancer eradication in combination with anti-PD-1 therapy

Maharjan, R.*, Choi, J. U.*, Kweon, S., Pangeni, R., Lee, N. K., Park, S. J., … Byun, Y.

Biomaterials281IF 15.3상위 2.8%doi:10.1016/j.biomaterials.2021.121334

Metronomic dose-finding approach in oral chemotherapy by experimentally-driven integrative mathematical modeling

Kweon, S.*, Jeong, Y. S.*, Chung, S. W., Lee, H., Lee, H., Park, S. J., … Byun, Y.

Biomaterials286IF 15.3상위 2.8%doi:10.1016/j.biomaterials.2022.121584

Caspase-3 mediated switch therapy of self-triggered and long-acting prodrugs for metastatic triple-negative breast cancer

Kim, H.*, Cho, Y. S.*, Chung, S. W., Choi, J. U., Ko, Y. G., Park, S. J., … Byun, Y.

Journal of Controlled Release346, 136–147IF 11.5상위 3.2%doi:10.1016/j.jconrel.2022.04.014

Sustained potentiation of bystander killing via PTEN-loss driven macropinocytosis targeted peptide-drug conjugate therapy in metastatic triple-negative breast cancer

Cho, Y. S.*, Kim, H.*, Park, S. J., Chung, S. W., Ko, Y. G., Yeo, J. H., … Byun, Y.

Biomaterials289IF 15.3상위 2.8%doi:10.1016/j.biomaterials.2022.121783

Caspase-cleavable peptide-doxorubicin conjugate in combination with CD47-antagonizing nanocage therapeutics for immune-mediated elimination of colorectal cancer

Lee, N. K.*, Choi, J. U.*, Kim, H. R., Chung, S. W., Ko, Y. G., Cho, Y. S., Park, S. J., … Byun, Y.

Biomaterials277IF 15.3상위 2.8%doi:10.1016/j.biomaterials.2021.121105

Anticoagulation therapy promotes the tumor immune-microenvironment and potentiates the efficacy of immunotherapy by alleviating hypoxia

Choi, J. U.*, Lee, N. K.*, Seo, H., Chung, S. W., Al-Hilal, T. A., Park, S. J., … Byun, Y.

Journal for ImmunoTherapy of Cancer9(8)IF 13.8상위 4.63%doi:10.1136/jitc-2021-002332